Literature DB >> 31904481

Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240/microRNA-124-3p/STAT3/MICA axis.

Yan Zhang1, Xing Li1, Jun Zhang1, Hua Liang2.   

Abstract

Long noncoding RNAs play significant roles in diverse cancers. In this study, we found that LINC00240 expression was markedly increased in cervical cancer. Functional in vitro assays in cervical cancer cells showed that LINC00240 enhanced the growth, migration, and invasion of cervical cancer cells. The target of LINC00240 was confirmed as microRNA(miR)-124-3p. Inhibition of miR-124-3p significantly enhanced cervical cancer progression via targeting of STAT3, which is greatly activated in tumor-infiltrating immune cells. LINC00240 expression was able to induce STAT3 expression via sponging of miR-124-3p, and showed a positive association with STAT3 expression in cervical cancer tissues. MHC class I-related chain (MIC)-A plays a key role in activating natural killer T (NKT) cells and serves as a downstream target of STAT3. Here, MICA was inhibited by up-regulation of LINC00240, and could be rescued by STAT3 knockdown. In addition, LINC00240 overexpression suppressed the cytotoxic activity of NKT cells by affecting the STAT3/MICA axis. Subsequently, we found that LINC00240 expression promoted cervical cancer progression via induction of miR-124-3p/STAT3/MICA-mediated NKT cell tolerance. Considering these findings, we conclude that LINC00240 might be a novel target for cervical cancer.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cervical cancer; LINC00240; MICA; STAT3; miR-124-3p

Year:  2020        PMID: 31904481     DOI: 10.1016/j.canlet.2019.12.038

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

Review 1.  Long non-coding RNAs and cancer mechanisms: Immune cells and inflammatory cytokines in the tumor microenvironment.

Authors:  Peipei Yang; Jie Ding; Yibo Bian; Zhonghua Ma; Keming Wang; Juan Li
Journal:  Med Oncol       Date:  2022-05-17       Impact factor: 3.064

2.  A four immune-related long noncoding RNAs signature as predictors for cervical cancer.

Authors:  Min Xu; Runjie Zhang; Jin Qiu
Journal:  Hum Cell       Date:  2021-11-30       Impact factor: 4.174

Review 3.  MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers.

Authors:  Mehdi Sajjadi-Dokht; Talar Ahmad Merza Mohamad; Heshu Sulaiman Rahman; Marwah Suliman Maashi; Svetlana Danshina; Navid Shomali; Saeed Solali; Faroogh Marofi; Elham Zeinalzadeh; Morteza Akbari; Ali Adili; Ramin Aslaminabad; Majid Farshdousti Hagh; Mostafa Jarahian
Journal:  Genes Dis       Date:  2021-12-03

4.  KLF2-induced circZKSCAN1 potentiates the tumorigenic properties of clear cell renal cell carcinoma by targeting the miR-1294/PIM1 axis.

Authors:  Mingzi Li; Mingxun Zhang; Muling Chen; Jiantao Xiao; Xingyu Mu; Jingtao Peng; Jie Fan
Journal:  Cell Cycle       Date:  2022-03-14       Impact factor: 5.173

5.  STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis.

Authors:  Tuo Liang; Jiarui Chen; GuoYong Xu; Zide Zhang; Jiang Xue; Haopeng Zeng; Jie Jiang; Tianyou Chen; Zhaojie Qin; Hao Li; Zhen Ye; Yunfeng Nie; Xinli Zhan; Chong Liu
Journal:  BMC Immunol       Date:  2022-01-22       Impact factor: 3.615

6.  Integrated Bioinformatical Analysis Identifies GIMAP4 as an Immune-Related Prognostic Biomarker Associated With Remodeling in Cervical Cancer Tumor Microenvironment.

Authors:  Fangfang Xu; Jiacheng Shen; Shaohua Xu
Journal:  Front Cell Dev Biol       Date:  2021-01-21

Review 7.  Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment.

Authors:  Yunkai Yang; Yan Wang
Journal:  Front Immunol       Date:  2021-04-02       Impact factor: 7.561

8.  Transcriptomic analysis and competing endogenous RNA network in the human endometrium between proliferative and mid-secretory phases.

Authors:  Seong-Lan Yu; Tae-Hyun Kim; Young-Hyun Han; Yujin Kang; Da-Un Jeong; Dong Chul Lee; Jaeku Kang; Seok-Rae Park
Journal:  Exp Ther Med       Date:  2021-04-20       Impact factor: 2.447

Review 9.  miRNA-based biomarkers, therapies, and resistance in Cancer.

Authors:  Boxue He; Zhenyu Zhao; Qidong Cai; Yuqian Zhang; Pengfei Zhang; Shuai Shi; Hui Xie; Xiong Peng; Wei Yin; Yongguang Tao; Xiang Wang
Journal:  Int J Biol Sci       Date:  2020-07-19       Impact factor: 6.580

10.  miR‑124‑3p regulates angiogenesis in peripheral arterial disease by targeting STAT3.

Authors:  Yefei Shi; Xu Xu; Peipei Luan; Wenxin Kou; Mingjie Li; Qing Yu; Jianhui Zhuang; Yawei Xu; Wenhui Peng; Weixia Jian
Journal:  Mol Med Rep       Date:  2020-09-25       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.